New subtype of breast cancer responds to targeted drug
February 28, 2010 by admin · Leave a Comment
Contact: Gwen Ericson
ericsong@wustl.edu
314-286-0141
Washington University School of Medicine
A newly identified cancer biomarker could define a new subtype of breast cancer as well as offer a potential way to treat it, say researchers at Washington University School of Medicine in St. Louis. Their findings will be published in the March 1 online early edition issue of the Proceedings of the National Academy of Sciences.
Newer cornea transplant surgery shows short- and long-term promise
February 28, 2010 by admin · Leave a Comment
Contact: Jessica Studeny
jessica.studeny@case.edu
216-368-4692
Case Western Reserve University Read more
A new generation of rapid-acting antidepressants?
February 28, 2010 by admin · Leave a Comment
Contact: Maureen Hunter
m.hunter@elsevier.com
215-239-3674
Elsevier
Philadelphia, PA, 1 March 2010 - Conventional antidepressant treatments generally require three to four weeks to become effective, thus the discovery of treatments with a more rapid onset is a major goal of biological psychiatry. The first drug found to produce rapid improvement in mood was the NMDA glutamate receptor antagonist, ketamine.
Researchers fishing for cancer cure discover active DHA derivatives
February 28, 2010 by admin · Leave a Comment
Contact: Cody Mooneyhan
cmooneyhan@faseb.org
301-634-7104
Federation of American Societies for Experimental Biology Read more
New testing method hints at garlic’s cancer-fighting potential
February 28, 2010 by admin · Leave a Comment
Contact: Earl Harrison
harrison.304@osu.edu
614-292-8189
Ohio State University
COLUMBUS, Ohio Researchers have designed a urine test that can simultaneously measure the extent of a potential carcinogenic process and a marker of garlic consumption in humans.
UMass Lowell researchers’ findings suggest new ways to diagnose and treat Alzheimer’s
February 28, 2010 by admin · Leave a Comment
Contact: Christine Gillette
Christine_Gillette@uml.edu
978-934-2209
IOS Press Read more
Critical brain chemical shown to play role in severe depression
February 28, 2010 by admin · Leave a Comment
Contact: Michael Torres
media@camh.net
416-595-6015
Centre for Addiction and Mental Health
TORONTO, March 1 /CNW/ - The next advance in treating major depression may relate to a group of brain chemicals that are involved in virtually all our brain activity, according to a study published today in Biological Psychiatry. The study is co-authored by Drs. Andrea J. Levinson and Zafiris J. Daskalakis of the Centre for Addiction and Mental Health (CAMH).
Targeted delivery of losartan reduces liver inflammation and scarring
February 28, 2010 by admin · Leave a Comment
Contact: Dawn Peters
medicalnews@wiley.com
781-388-8408
Wiley-Blackwell Read more
Drug dramatically reduces nausea and vomiting in bone marrow transplant patients
February 28, 2010 by admin · Leave a Comment
Contact: Jim Ritter
jritter@lumc.edu
708-216-2445
Loyola University Health System
Bone marrow transplant patients say two of the most debilitating side effects of the treatment are nausea and vomiting caused by chemotherapy and radiation.
Ghrelin mitigates liver fibrosis in animal models; regulates human fibrosis
February 28, 2010 by admin · Leave a Comment
Contact: Dawn Peters
medicalnews@wiley.com
781-388-8408
Wiley-Blackwell Read more
